{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:50:19Z","timestamp":1777099819850,"version":"3.51.4"},"reference-count":44,"publisher":"Consilium Medicum","issue":"10","license":[{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Thyroid cancer is the most common malignant tumor of the endocrine system. An increase in the incidence of thyroid cancer has been noted over the past decade, mainly due to papillary cancer. The influence of environmental factors, increased availability of medical care, including sensitive diagnostic tests, such as ultrasound and fine - needle aspiration (FNA), can affect the fact of the growth of this incidence. Palpation of thyroid gland has very low diagnostic value for detecting thyroid cancer, while thyroid ultrasound and FNA can detect malignant tumors in 20% of cases. Today, the FNA is the fastest, most accurate, economically accessible, and quite safe method for cytological diagnosis of the thyroid nodules. And molecular genetic testing of FNA samples could serve as an additional reliable diagnostic tool in the case of atypia of undetermined significance.<\/jats:p>","DOI":"10.26442\/00403660.2019.10.000357","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T22:30:51Z","timestamp":1574980251000},"page":"119-123","source":"Crossref","is-referenced-by-count":1,"title":["Molecular markers as risk factors for thyroid cancer"],"prefix":"10.26442","volume":"91","author":[{"given":"M O","family":"Rogova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S V","family":"Novosad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N S","family":"Martirosian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L V","family":"Trukhina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N A","family":"Petunina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14341\/serg201615-12"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0520"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930540204"},{"key":"ref4","unstructured":"Nikiforov Y.E. Thyroid tumors: Classification and general considerations. In: Nikiforov Y.E, Biddinger P.W, Thompson L.D.R, eds. Diagnostic pathology and molecular genetcis of the thyroid. Baltimore: Lippincott Williams & Wilkins, 2009. P. 94-102."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0240"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPPHLWMI3JV4LA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1469"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0020"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31245"},{"key":"ref10","unstructured":"Kimura E.T, Nikiforova M.N, Zhu Z, Knauf J.A, Nikiforov Y.E, Fagin J.A. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC - RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003;63(7):1454-7."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.0978"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0047"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030305"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1125"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206706"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0337"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0987"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0607"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2010.09.005"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2009.09.011"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.10.012"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0233-3"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.8592"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00704.x"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2000.10.19"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000176432.73455.1b"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1309\/nd8d-9laj-trct-g6qd"},{"key":"ref28","unstructured":"Powell D.J.Jr, Russell J, Nibu K, et al. The RET\/PTC3 oncogene: metastatic solid - type papillary carcinomas in murine thyroids. Cancer Res. 1998;58(23):5523-8."},{"key":"ref29","unstructured":"Tallini G, Santoro M, Helie M, et al. RET\/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res. 1998;4(2):287-94."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1385\/EP:13:1:03"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.11.5271"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.7.3211"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1043\/1543-2165(2004)128<807:atatcc>2.0.co;2"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03646.x"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5483.1357"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021907"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63902-8"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.20063"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.446"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.5094"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0210"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4048"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3185"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3734"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/33716\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/33716\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T21:20:17Z","timestamp":1634160017000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/33716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,15]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2019.10.000357","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}